JosephG. F.RosalesMD

Oncology • Spokane, WA

Physician

Join to view full profile

Dr. Rosales is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rosales' full profile

Already have an account?

Office
6001 North Mayfair
Spokane, WA 99208
Phone+1 509-462-2273

Fax+1 509-462-2275

Education & Training

Los Angeles County-Harbor-UCLA Medical Center 1Fellowship, Hematology and Medical Oncology, 2003 - 2006
St Mary Medical CenterResidency, Internal Medicine, 1999 - 2003
David Geffen School of Medicine at UCLAClass of 1999

Certifications & Licensure

CA State Medical License 2001 - Present
WA State Medical License 2006 - 2025

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification HealthSentry EHR, Cerner Corporation, 2013

Publications & Presentations

PubMed

32 citations
Impact of initial imaging with gallium-68 dotatate PET/CT on diagnosis and management of patients with neuroendocrine tumors.
Angelena Crown, Flavio G. Rocha, Preethi Raghu, Bruce S. Lin, Gayle Funk
Journal of Surgical Oncology. 2020-03-01
6 citations
Phase II trial of carfilzomib plus irinotecan in patients with small-cell lung cancer who have progressed on prior platinum-based chemotherapy
Susanne M. Arnold, Kari Chansky, Maria Q. Baggstrom, Michael A. Thompson, Rachel E. Sanborn
Clinical Lung Cancer. 2020-01-27
15 citations
The impact of neoadjuvant chemoradiotherapy on perioperative outcomes, tumor pathology, and survival in clinical stage II and III esophageal cancer.
Sheraz R. Markar, Artur M. Bodnar, Joseph Grant F Rosales, G. Song, Donald E. Low
Annals of Surgical Oncology. 2013-07-27

Press Mentions

Cancer Drug Shortages Lead to Heart-Wrenching Decisions at Washington HospitalsJune 5th, 2023
'More Effective, Less Toxic': How Oncology Could Change in 50 YearsSeptember 13th, 2023